{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:19:45Z","timestamp":1777396785338,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,1,30]]},"abstract":"<jats:p>Background: The FACEmemory\u00ae online platform comprises a complex memory test and sociodemographic, medical, and family questions. This is the first study of a completely self-administered memory test with voice recognition, pre-tested in a memory clinic, sensitive to Alzheimer\u2019s disease, using information and communication technologies, and offered freely worldwide. Objective: To investigate the demographic and clinical variables associated with the total FACEmemory score, and to identify distinct patterns of memory performance on FACEmemory. Methods: Data from the first 3,000 subjects who completed the FACEmemory test were analyzed. Descriptive analyses were applied to demographic, FACEmemory, and medical and family variables; t-test and chi-square analyses were used to compare participants with preserved versus impaired performance on FACEmemory (cut-off\u200a=\u200a32); multiple linear regression was used to identify variables that modulate FACEmemory performance; and machine learning techniques were applied to identify different memory patterns. Results: Participants had a mean age of 50.57 years and 13.65 years of schooling; 64.07% were women, and 82.10% reported memory complaints with worries. The group with impaired FACEmemory performance (20.40%) was older, had less schooling, and had a higher prevalence of hypertension, diabetes, dyslipidemia, and family history of neurodegenerative disease than the group with preserved performance. Age, schooling, sex, country, and completion of the medical and family history questionnaire were associated with the FACEmemory score. Finally, machine learning techniques identified four patterns of FACEmemory performance: normal, dysexecutive, storage, and completely impaired. Conclusions: FACEmemory is a promising tool for assessing memory in people with subjective memory complaints and for raising awareness about cognitive decline in the community.<\/jats:p>","DOI":"10.3233\/jad-230983","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:09:10Z","timestamp":1704802150000},"page":"1173-1187","source":"Crossref","is-referenced-by-count":3,"title":["FACEmemory\u00ae, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants"],"prefix":"10.1177","volume":"97","author":[{"given":"Montserrat","family":"Alegret","sequence":"first","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Ortega","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Lleonart","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maitee","family":"Rosende-Roca","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Pytel","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahveth","family":"Cantero-Fortiz","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Neurology, Massachusetts General Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Butler","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Department of Brain Sciences, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[{"name":"Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain"},{"name":"Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230983_ref1","doi-asserted-by":"crossref","unstructured":"(2023) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 19, 1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"10.3233\/JAD-230983_ref2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1041610209991748","article-title":"Early intervention for cognitive decline: Can cognitive training be used as a selective prevention technique?","volume":"22","author":"Mowszowski","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-230983_ref3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.3233\/JAD-230983_ref4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/psyg.12944","article-title":"Aducanumab for the treatment of Alzheimer\u2019s disease: a systematic review","volume":"23","author":"Rahman","year":"2023","journal-title":"Psychogeriatrics"},{"key":"10.3233\/JAD-230983_ref5","first-page":"1112106","article-title":"Building a responsible innovation toolkit as project legacy","volume":"88","author":"Stahl","year":"2021","journal-title":"Front Res Metr Anal"},{"key":"10.3233\/JAD-230983_ref6","first-page":"266","article-title":"Cambridge neuropsychological test automated battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers","volume":"5","author":"Robbins","year":"1994","journal-title":"Dementia"},{"key":"10.3233\/JAD-230983_ref7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jalz.2015.01.008","article-title":"Performance of the CogState computerized battery in the Mayo Clinic Study on Aging","volume":"11","author":"Mielke","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230983_ref8","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.3390\/jcm11144191","article-title":"Digital cognitive biomarker for mild cognitive impairments and dementia: a systematic review","volume":"11","author":"Ding","year":"2022","journal-title":"J Clin Med"},{"key":"10.3233\/JAD-230983_ref9","first-page":"8","article-title":"The feasibility of at-home iPad cognitive testing for use in clinical trials","volume":"3","author":"Rentz","year":"2016","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-230983_ref10","first-page":"59","article-title":"The computerized cognitive composite (C3) in A4, an Alzheimer\u2019s disease secondary prevention trial","volume":"8","author":"Papp","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-230983_ref11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-020-00594-6","article-title":"A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory\u00ae) for the early detection of Alzheimer\u2019s disease","volume":"12","author":"Alegret","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230983_ref12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13195-022-00988-8","article-title":"Automatized FACEmemory\u00ae scoring is related to Alzheimer\u2019s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort","volume":"14","author":"Alegret","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230983_ref13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3233\/JAD-122002","article-title":"A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved","volume":"34","author":"Espinosa","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230983_ref14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0010-9452(08)70689-0","article-title":"Are faces special in Alzheimer\u2019s disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names","volume":"43","author":"Werheid","year":"2007","journal-title":"Cortex"},{"key":"10.3233\/JAD-230983_ref15","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","article-title":"Face-name associative memory performance is related to amyloid burden in normal elderly","volume":"49","author":"Rentz","year":"2011","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-230983_ref16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3233\/JAD-150594","article-title":"Concordance between subjective and objective memory impairment in volunteer subjects","volume":"48","author":"Alegret","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230983_ref17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-160915","article-title":"Impact of recruitment methods in subjective cognitive decline","volume":"57","author":"Abdelnour","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230983_ref18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/alz.12297","article-title":"Identification of undiagnosed dementia cases using a web-based pre-screening tool: the MOPEAD project","volume":"17","author":"Rodrigo","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230983_ref19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/13854046.2014.911351","article-title":"Development of a psychometrically equivalent short form of the face-name associative memory exam for use along the early Alzheimer\u2019s disease trajectory","volume":"28","author":"Papp","year":"2014","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-230983_ref20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/arclin\/acv050","article-title":"Validation of the Spanish version of the face name associative memory exam (S-FNAME) in cognitively normal older individuals","volume":"30","author":"Alegret","year":"2015","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JAD-230983_ref22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann Statist"},{"key":"10.3233\/JAD-230983_ref23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.2008.158964","article-title":"Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease","volume":"80","author":"Lopez","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-230983_ref24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.neuroimage.2010.09.005","article-title":"Fractionating verbal episodic memory in Alzheimer\u2019s disease","volume":"54","author":"Wolk","year":"2011","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-230983_ref25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1757913918802308","article-title":"Public health delivery in the information age: the role of informatics and technology","volume":"139","author":"Williams","year":"2019","journal-title":"Perspect Public Health"},{"key":"10.3233\/JAD-230983_ref26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13854046.2016.1190405","article-title":"Online cognition: factors facilitating reliable online neuropsychological test results","volume":"31","author":"Feenstra","year":"2017","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-230983_ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-014-0539-z","article-title":"Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer\u2019s disease","volume":"264","author":"Jessen","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-230983_ref28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.pneurobio.2011.08.014","article-title":"Prevention trials in Alzheimer\u2019s disease: an EU-US task force report","volume":"95","author":"Vellas","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-230983_ref29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230983_ref30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.3233\/JAD-230983_ref31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1532-5415.2004.52066.x","article-title":"Subjective memory complaints and objective memory impairment in the Vienna\u2013Transdanube aging community","volume":"52","author":"Jungwirth","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-230983_ref32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-230983_ref33","first-page":"173","article-title":"Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies.afac","volume":"51","author":"Bai","year":"2022","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-230983_ref34","first-page":"1","article-title":"Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals","volume":"4046","author":"Kormas","year":"2018","journal-title":"Clin Neuropsychol"},{"issue":"sup1","key":"10.3233\/JAD-230983_ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13854046.2019.1690050","article-title":"Validation of the Latin American Spanish version of the face-name associative memory exam in a Colombian sample","volume":"34","author":"Vila-Castelar","year":"2020","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-230983_ref36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/13803395.2012.666230","article-title":"Validation of the Face Name Associative Memory Exam in cognitively normal older individuals","volume":"34","author":"Amariglio","year":"2012","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-230983_ref37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S1355617721000084","article-title":"Validation and normative data of the Spanish version of the Face Name Associative Memory Exam (S-FNAME)","volume":"28","author":"Alviarez-Schulze","year":"2021","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-230983_ref38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:17Z","timestamp":1777370957000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":37,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-230983","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2965959\/v1","asserted-by":"object"}]},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}